Differential Regulation of two Molecular Forms of a μ-Opioid Receptor Type by Sodium Ions, Manganese Ions and by Guanyl-5′-YL Imidodiphosphate

References

• Lord J.A.H., Waterfield A.A., Hughes J., Kosterlitz H.W. Endogenous opioid peptides: multiple agonists and receptors. Nature (London) 1977; 267: 495–500
   PubMed Web of Science ®Google Scholar
• Chang K.-J., Cuatrecasas P. Multiple opiate receptors: enkephalins and morphine bind to receptors of different specificity. J. Biol. Chem. 1979; 254: 2610–2618
   PubMed Web of Science ®Google Scholar
• Kosterlitz H.W., Paterson S.J., Robson L.E. Characterisation of the kappa subtype of the opiate receptor in the guinea-pig brain. Brit. J. Pharmacol. 1981; 73: 939–949
   PubMed Web of Science ®Google Scholar
• Chang K.-J., Hazum E., Cuatrecasas P. Novel opiate binding sites selective for benzomorphan drugs. Proc. Natl. Acad. Sci. USA 1981; 78: 4141–4145
   PubMedGoogle Scholar
• Bowen W.D., Gentleman S., Herkenham M., Pert C.B. Interconverting μ and δ forms of the opiate receptor in rat striatal patches. Proc. Natl. Acad. Sci. USA 1981; 78: 4818–4822
   PubMed Web of Science ®Google Scholar
• Sharma S.K., Nirenberg M., Klee W.A. Morphine receptors as regulators of adenylate cyclase activity. Proc. Natl. Acad. Sci. USA 1975; 72: 590–594
   PubMed Web of Science ®Google Scholar
• Cooper D.M.F., Londos C., Gill D.L., Rodbell M. Opiate receptor-mediated inhibition of adenylate cyclase in rat striatal plasma membranes. J. Neurochem. 1982; 38: 1164–1167
   PubMed Web of Science ®Google Scholar
• Blume A.J., Lichtshtein D., Boone G. Coupling of opiate receptors to adenylate cyclase: requirement for Na and GTP. Proc. Natl. Acad. Sci. USA 1979; 76: 5626–5630
   PubMedGoogle Scholar
• Koski G., Klee W.A. Opiates inhibit adenylate cyclase by stimulating GTP hydrolysis. Proc. Natl. Acad. Sci. USA 1981; 78: 4185–4189
   PubMed Web of Science ®Google Scholar
• Koski G., Streaty R.A., Klee W.A. Modulation of sodium-sensitive GTP-ase by partial opiate agonists. An explanation for the dual requirement for Na and GTP in inhibitory regulation of adenylate cyclase. J. Biol. Chem. 1982; 257: 14035–14040
   PubMedGoogle Scholar
• Childers S.R., Snyder S.H. Differential regulation by guanine nucleotides of opiate agonist and antagonist receptor interactions. J. Neurochem. 1980; 34: 583–593
   PubMedGoogle Scholar
• Zukin R.S., Walczak S., Makman M.H. GTP modulation of opiate receptors in regions of rat brain and possible mechanism of GTP action. Brain Res. 1980; 186: 238–244
   Google Scholar
• Pfeiffer A., Sadée W., Herz A. Differential regulation of the μ, δ and κ opiate receptors subtypes by guanine nucleotides and metal ions. J. Neurosci. 1982; 2: 912–917
   Google Scholar
• Ross E.M., Gilman A.G. Biochemical properties of hormone sensitive adenylate cyclase. Ann. Rev. Biochem. 1980; 49: 533–564
   PubMed Web of Science ®Google Scholar
• Rodbell M. The role of hormone receptors and GTP regulatory proteins in membrane transduction. Nature (London) 1980; 284: 17–22
   PubMed Web of Science ®Google Scholar
• Meunier J.C. μ and κ opiate binding sites in the rabbit CNS. Life Sci. 1982; 31: 1327–1330
   Google Scholar
• Meunier J.C., Kouakou Y., Puget A., Moisand C. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a μ subtype in the cerebellum and characterization of a κ subtype in the thalamus. Mol. Pharmacol. 1983; 24: 23–29
   PubMed Web of Science ®Google Scholar
• Simon E.J., Hiller J.M., Edelman I. Solubilization of a stereospecific oopiate-macromolecular complex from the rat brain. Science (Wash.D.C.) 1975; 190: 389–390
   PubMed Web of Science ®Google Scholar
• Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265–270
   PubMed Web of Science ®Google Scholar
• Chance B., Maehly A.C. Assay of catalases and peroxydases. Methods in Enzymology, S.P. Colowick, N.O. Kaplan. Academic Press, New-York 1955; vol II: 764–775
   Google Scholar
• Ellman G.L., Courtney K.D., Andres V., Jr., Featherstone R.H. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961; 7: 88–95
   PubMed Web of Science ®Google Scholar
• Racker E. Alcohol dehydrogenase from baker's yeast. Methods in Enzymology, S.P. Colowick, N.O. Kaplan. Academic Press, New-York 1955; vol. I: 500–503
   Google Scholar
• Von Voigtlander P.F., Lahti R.A., Ludens J.H. U-50488: a selective and structurally novel non-μ (κ) opioid agonist. J. Pharmacol. Exp. Ther. 1983; 224: 7–12
   PubMed Web of Science ®Google Scholar
• Feinberg A.P., Creese I., Snyder S.H. The opiate receptor: a model explaining structure-activity relationships of opiate agonists and antagonists. Proc. Natl. Acad. Sci. USA 1976; 73: 4215–4219
   PubMed Web of Science ®Google Scholar
• Pert C.B., Pasternak G., Snyder S.H. Opiate agonists and antagonists descriminated by receptor binding in brain. Science (Wash.D.C.) 1973; 182: 1359–1361
   PubMed Web of Science ®Google Scholar
• Simon E.J., Hiller J.M., Groth J., Edelman I. Further properties of stereospecific binding sites in rat brain: on the nature of the sodium effect. J. Pharmacol. Exp. Ther. 1975; 192: 531–537
   PubMed Web of Science ®Google Scholar
• Pasternak G.N., Snowman A.S., Snyder S.H. Selective enhancement of opiate agonist binding by divalent cations. Mol. Pharmacol. 1975; 11: 735–744
   PubMed Web of Science ®Google Scholar
• Kouakou Y.P., Zajac J.M., Moisand C., Meunier J.C. The opiate receptor binding interactions of opioid alkaloids and of an opioid peptide in rat brain membranes: selection by manganese ions and by cholic acid (sodium salt) and minimalization of cross-reaction in vitro. Mol. Pharmacol. 1982; 21: 564–569
   Google Scholar
• Northup J.K., Smigel M.D., Sternweiss P.C., Gilman A.G. The subunits of the stimulatory regulatroy component of adenylate cyclase. Resolution of activated 45,000 dalton (α) subunit. J. Biol. Chem. 1983; 258: 11369–11376
   PubMed Web of Science ®Google Scholar
• Codina J., Hildebrandt J., Iyengar R., Birnbaumer L., Sekura R.D., Manclark C.R. Pertussis toxin substrate, the putative N1 component of adenylyl cyclases, is an αβ heterodimer regulated by guanine nucleotide and magnesium. Proc. Natl. Acad. Sci. USA 1983; 80: 4276–4280
   PubMed Web of Science ®Google Scholar
• Limbird L.E., Lefkowitz R.J. Agonist induced increase in apparent β-adrenergic receptor size. Proc. Natl. Acad. Sci. U.S.A. 1978; 75: 228–232
   PubMedGoogle Scholar
• Limbird L.E., Gill D.M., Stadel J.M., Hickey A.R., Leftkowitz R.J. Loss of β-adrenergic receptor guanine nucleotide regulatory protein interactions accompanies decline in catecholamine responsiveness of adenylate cyclase in maturating rat erythrocytes. J. Biol. Chem. 1982; 255: 1854–1861
   Google Scholar
• Smith S.K., Limbird L.E. Solubilization of human platelet α-adrenergic receptors: evidence that agonist occupancy of the receptor stabilizes receptor-effector interactions. Proc. Natl. Acad. Sci. USA 1981; 78: 4026–4030
   PubMedGoogle Scholar
• Smith S.K., Limbird L.E. Evidence that human platelet α-adrenergic receptors coupled to inhibition of adenylate cyclase are not associated with the subunit of adenylate cyclase ADP-ribosylated by cholera toxin. J. Biol. Chem. 1982; 257: 10471–10478
   PubMed Web of Science ®Google Scholar
• Kilpatrick B.F., Caron M.G. Agonist binding promotes a guanine nucleotide reversible increase in the apparent size of the bovine anterior pituitary dopamine receptors. J. Biol. Chem. 1983; 258: 13528–13534
   PubMed Web of Science ®Google Scholar
• De Léan A., Ong H., Gutkowska J., Schiller P.W., Mc Nicoll N. Evidence for antagonist induced interaction of angiotensin receptor with a guanine nucleotide binding protein in bovine adrenal zona glomerulosa. Mol. Pharmacol. 1984; 26: 498–508
   PubMed Web of Science ®Google Scholar
• Puget A., Meunier J.C. Récepteur(s) des opiacés du cerveau de grenouille: sépation en phase soluble des complexes macromoléculaires d'un agoniste et d'un antagoniste. C.R. Acad. Sci. 1983; 296-III: 475–478, Paris
   Google Scholar
• Ruegg U.T., Cuenod S., Hiller J.M., Gioannini T., Howells R.D., Simon E.J. Characterization and partial purification of solubilized active opiate receptors from toad brain. Proc. Natl. Acad. Sci. USA 1981; 78: 4635–4638
   PubMed Web of Science ®Google Scholar
• Simon J., Szücs M., Benyle S., Borsodi A., Zeman P., Wolleman M. Solubilization and characterization of opioid binding sites from frog (Rana esculenta) brain. J. Neurochem. 1984; 43: 957–963
   Google Scholar
• Puget A., Frances B., Jauzac Ph., Meunier J.C. Solubilization of two molecular forms of the frog brain opioid receptor. Neuropeptides. 1984; 5: 129–132
   Google Scholar
• Duggan A.W., North R.A. Electrophysiology of oploids. Pharmacological Reviews. 1983; 35: 219–281
   PubMed Web of Science ®Google Scholar
• North R.A., Williams J.T. On the potassium conductance increased by opioids it rat locus coeruleus neurones. J. Physiol. 1985; 364: 265–280
   Google Scholar
• Brown D.A., Adams P.R. Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone. Nature (London) 1980; 283: 673–676
   PubMed Web of Science ®Google Scholar
• Pfaffinger P.J., Martin J.M., Hunter D.D., Nathanson N.M., Hille B. GTP-binding proteins couple cardiac muscarinic receptors to a K channel. Nature (London) 1985; 317: 536–538
   PubMed Web of Science ®Google Scholar
• Breitwieser G.E., Szabo G. Uncoupling of cardiac muscarinic and β-adrenergic receptors from ion channels by a guanine nucleotide analogue. Nature (London) 1985; 317: 538–540
   PubMed Web of Science ®Google Scholar
• Kandel E.R., Schwartz J.H. Molecular biology of learning: modulation of transmitter release. Science (Wash.D.C.) 1982; 218: 433–443
   PubMed Web of Science ®Google Scholar
• Sternweiss P.C., Robishaw J.D. Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain. J. Biol.Chem. 1984; 259: 13806–13813
   Google Scholar